Est. 1802 ·
  • DPH Urging At-Risk Individuals To Get Vaccinated After MPOX Case Appears In Connecticut

    By CT Centinal Staff
    May 14, 2026
    0

    Coincidentally, the World Health Organization started stockpiling mpox vaccines in 2026.

    Colorized transmission electron micrograph of two mature mpox virus particles (pink) attached to the surface of an infected VERO E6 cell (blue/teal) per NIAID (2024)

    Please Follow us on GabMindsTelegramRumble, Gettr, Truth SocialTwitterYouTube

    The Connecticut Department of Public Health (DPH) has identified the first case of clade I mpox in Connecticut through testing performed at the State Public Health Laboratory. The person with this case recently traveled to Western Europe, where clade I mpox is currently spreading. This case does not pose a risk to the general public.

    DPH warns that mpox is still spreading around the world and in the United States, and continues to affect gay and bisexual men and other men who have sex with men more than other groups. DPH urges people who may be at risk to get fully vaccinated with the JYNNEOS vaccine.“

    "Mpox hasn’t gone away, and we want people to be protected, especially as many in our community prepare for travel, festivals, and gatherings this summer,” said DPH Commissioner Manisha Juthani, M.D. “The vaccine is safe, effective, and widely available. Completing the two-dose series is the best way to protect yourself and your partners.”

    DPH asserts that “vaccination is the best way to protect yourself” and strongly recommends that people at risk get two doses of the JYNNEOS vaccine.

    However, DPH fails to mention several important limitations: reduced effectiveness in people with HIV, the potential for breakthrough infections after two doses, waning immunity levels after 6–12 months (which has prompted calls for booster shots), and possible side effects, including cardiac and other serious events.

    According to the JYNNEOS package insert, a causal relationship to the vaccine could not be excluded for five serious adverse events (SAEs), all non-fatal: Crohn’s disease, sarcoidosis, extraocular muscle paresis, throat tightness, and hemolytic anemia.

    Among cardiac adverse reactions of special interest, six cases were considered causally related to JYNNEOS vaccination. These included tachycardia, electrocardiogram T-wave inversion, abnormal electrocardiogram, ST segment elevation, abnormal T wave, and palpitations.

    Brownstone Institute article in August 2023, noted that Jynneos failed to prevent infection in its trials.

    Dr. Peter McCullough also warned about the mpox vaccines on X: “The Bavarian Nordic Monkeypox vaccine causes myocarditis and is not worth the risk for this low prevalence, avoidable, and easily manageable condition.”

    By the way Connecticut is not alone is urging "at-risk individuals" to get vaccinated.

    Last month, Dr. Erica Pan, Director of the California Department of Public Health (CDPH) and State Public Health Officer encouraged "high-risk" Californians to get both doses amid rising cases in San Francisco.

    “This reinforces how important it is for people at higher risk to get both doses of the mpox vaccine. With summer travel and large events approaching, now is the ideal time to protect yourself if you or your sex partner may be at risk,” she said.

    Dr. Susan Philip, San Francisco Health Officer, and Dr. Sayone Thihalolipavan, M.D., MPH, San Diego County Public Health Officer, both echoed the comments, urging at-risk individuals to get vaccinated.

    Screenshot, WHO

    It's worth remembering that the World Health Organization released a “strategic framework for enhancing prevention and control of mpox” in 2024 which recommended “efforts to improve access to vaccines.”

    Not only that, but in November 2025, the WHO announced—alongside partners like UNICEF and with financial support from the Bill Gates-funded Gavi Alliance Board—that it would establish an mpox vaccine stockpile “to ensure a timely, equitable, sustainable and coordinated access to vaccines and supplies for mpox outbreak response and prevention.”

    Also recall that Connecticut joined other states to form the “Governors Public Health Alliance” in October 2025. The Alliance expressed disappointment with the Trump Administration’s decision to exit the WHO in January 2026, arguing that the move “undermined” public health.

    Governor Lamont called the decision to leave the WHO “irresponsible” and insisted he had a “responsibility” to the people to engage with the global health community in order to protect public health in the state. Hence yesterday’s DPH push urging “at-risk” individuals to get the mpox vaccine.

    Screenshot, WHO

    ‘NO AD’ subscription for CDM!  Sign up here and support real investigative journalism and help save the republic!'

    Subscribe
    Notify of
    guest

    0 Comments
    Oldest
    Newest Most Voted

    FOLLOW US

  • magnifiercrossmenu